48 results on '"Villaudy, Julien"'
Search Results
2. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
3. 770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients
4. Data from A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia
5. Supplementary Table & Figures from A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia
6. HTLV-1 Infection of Humanized NOD/SCID IL2 γc−/− and BALB/c-Rag2−/−γc−/− Mouse Models
7. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
8. Modeling human lung infections in mice
9. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
10. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
11. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
12. Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice
13. The Human Immune System mouse as a model to study morbidity and ageing in HIV infection
14. Interleukin-12 and -23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
15. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
16. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
17. Identification and characterization of auxiliary proteins encoded by the STLV-3 retrovirus pX region
18. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
19. Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL
20. 721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection
21. Abstract 531: AT1412, a patient-derived antibody in development for the treatment of CD9-positive precursor B-acute lymphoblastic leukemia
22. Abstract 532: A patient-derived anti-CD9 antibody induces tumor rejection and synergistically enhances anti-PD1 activity
23. Abstract 542: T-cell engager bispecific formats of an AML patient-derived antibody targeting a unique sialylated CD43 epitope induce kill of melanoma cells in vitro and in vivo
24. Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
25. AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia
26. A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia
27. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT)
28. Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice
29. Abstract LB-200: A patient derived antibody targeting the tetraspanin CD9 synergistically inhibits tumor growth with an anti PD1 antibody
30. An antibody derived from a cured AML patient to identify a unique epitope on CD43 (CD43s) as a novel target for acute myeloid leukemia and myelodysplastic syndrome.
31. Abstract A061: Acute myeloid leukemia patients cured after allogeneic hematopoietic stem cell transplantation generate tumor-specific cytotoxic antibodies that kill AML blasts
32. Abstract A026: Tumor-specific glycosylated CD43 is a novel and highly specific target for acute myeloid leukemia and myelodysplastic syndrome
33. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs
34. From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis
35. Développement d’un modèle de souris Rag2-/-γc-/- humanisée pour l’étude de l’infection et de la leucémogénèse associée à HTLV-1
36. Critical assessment of human antibody generation in humanized mouse models
37. Human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein induces DNA damages through Activation-Induced cytidine Deaminase (AID)
38. HTLV-1 Infection of Humanized NOD/SCID IL2 γc-/- and BALB/c-Rag2-/-γc-/- Mouse Models.
39. What we are learning on HTLV-1 pathogenesis from animal models
40. Les souris ne sont pas des hommes et pourtant…
41. HTLV-1 Propels Thymic Human T Cell Development in “Human Immune System” Rag2-/- gamma c-/- Mice
42. Identification and characterization of auxiliary proteins encoded by the STLV-3 retrovirus pX region
43. HTLV-1-infected HIS Rag2-/-γc-/- mice, a suitable model for in vivo investigating the effects of drugs in ATL treatment?
44. HTLV-1 propels thymic human T cell development in “human immune system” Rag2-/- IL-2R γc-/- Mice
45. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT)
46. HTLV-1 Propels Thymic Human T Cell Development in "Human Immune System" Rag2-/- gamma c-/- Mice.
47. HTLV-1 propels thymic human T cell development in “human immune system” Rag2-/- gamma c-/- Mice
48. [Mice are not Men and yet… how humanized mice inform us about human infectious diseases].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.